Chapter 78

Reference

  1. Armstrong M. 2000. The pathogenesis of human Acanthamoeba infection. Infect Dis Rev 2:65-73.
  2. Ayers KH, Billups LH, Garner FM. 1972. Acanthamebiasis in a dog. Vet Pathol 9:221-226.
  3. Bauer R. 1990. Experimental acanthamebiasis in the canine. Doctoral thesis, University of Georgia, Athens, GA.
  4. Bauer RW, Harrison LR, Watson CW, et al. 1993. Isolation of Acanthamoeba sp. from a greyhound with pneumonia and granulomatous amebic encephalitis. J Vet Diagn Invest 5:386-391.
  5. Brandt FH, Ware DA, Visvesvara GS. 1989. Viability of Acanthamoeba cysts in ophthalmic solutions. Appl Environ Microbiol 55:1144-1146.
  6. Brasseur G, Favenneck L, Perrine D, et al. 1994. Successful treatment of Acanthamoeba keratitis by hexamidine. Cornea 13:459-462.
  7. Brofman PJ, Knostman KAB, DiBartola SP. 2003. Granulomatous amebic meningoencephalitis causing the syndrome of inappropriate secretion of antidiuretic hormone in a dog. J Vet Intern Med 17:230-234.
  8. Buergelt CD, Harrison LR, Bauer RW. 1991. Diagnostic exercise: pneumonia and CNS disturbances in young greyhound dogs. Lab Anim Sci 41:76-77.
  9. Casper T, Basset D, Leclercq C, et al. 1999. Disseminated Acanthamoeba infection in a patient with AIDS: response to 5-fluorocytosine therapy. Clin Infect Dis 29:944-945.
  10. Clark DW, Kiederkorn JY. 2006. The pathophysiology of Acanthamoeba keratitis. Trends Parasitol 22:175-180.
  11. Culbertson CG. 1971. The pathogenicity of soil amebas. Annu Rev Microbiol 25:31-254.
  12. Culberston CG, Smith JW, Minner JR. 1958. Acanthamoeba: observations on animal pathogenicity. Science 127:1506.
  13. Das SR, Asiri AS, El-Soofi A. 1991. Protective and curative effects of rifampicin in Acanthamoeba meningitis of the mouse. J Infect Dis 163:916-917.
  14. Dubey JP, Benson JE, Blakeley KT, et al. 2005. Disseminated Acanthamoeba sp. infection in a dog. Vet Parasitol 128:183-187.
  15. Finnin PJ, Visvesvara GS, Campbell BE, et al. 2007. Multifocal Balamuthia mandrillaris infection in a dog in Australia. Parasitol Res 100:423-426.
  16. Foreman O, Sykes J, Ball L, et al. 2004. Disseminated infection with Balamuthia mandrillaris in a dog. Vet Pathol 41:506-510.
  17. 16a. Fritsche TR, Gautom RK, Seyedirashti S, et al. 1993. Occurrence of bacterial endosymbionts in Acanthamoeba spp. isolated from corneal and environmental specimens and contact lenses. J Clin Microbiol 31:1122-1126.
  18. 16b. Fritsche TR, Horn M, Wagner M, et al. 2000. Phylogenetic diversity among geographically dispersed Chlamydiales endosymbionts recovered from clinical and environmental isolates of Acanthamoeba spp. Appl Environ Microbiol 66:2613-2619.
  19. Garate M, Marchant J, Cubillos I, et al. 2006. In vitro pathogenicity of Acanthamoeba is associated with the expression of the mannose-binding protein. Invest Ophthalmol Vis Sci 47:1056-1062.
  20. Gelman BB, Rauf SJ, Nader R, et al. 2001. Amoebic encephalitis due to Sappinia diploidea. JAMA 285:2450-2451.
  21. Glaser C, Schuster F, Yagi S, et al. 2008. Balamuthia amebic encephalitis—California, 1999–2007. MMWR 57:768-771.
  22. González P, Carbonell E, Urios V, et al. 2007. Coprology of Panthera tigris altaica and Felis bengalensis euptilurus from the Russian Far East. J Parasitol 93:948-950.
  23. Greub G. 2009. Parachlamydia Acanthamoebae, an emerging agent of pneumonia. Clin Microbiol Infect 15:18-28.
  24. Griffin JL. 1978. Pathogenic free-living amoeba, pp 507-549. In Krier JP (ed): Parasitic protozoa, vol II. Academic Press, New York.
  25. Harrison LR, Bauer RW. 1990. Acanthamebiasis, pp 815-817. In Greene CE (ed): Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  26. 23a. Hodge PJ, Kelers K, Gasser RB, et al. 2011. Another case of canine amoebic meningoencephalitis—the challenges of reaching a rapid diagnosis. Parasitol Res 108:1069-1073.
  27. Howerth EW. 2010. Personal observations. University of Georgia, Athens, GA.
  28. Kent M. 2010. Personal communication. University of Georgia, Athens, GA.
  29. Kiderlen AF, Laube I. 2004. Balamuthia mandrillaris, an opportunistic agent of granulomatous amebic encephalitis, infects the brain via the olfactory nerve pathway. Parasitol Res 94:49-52
  30. Kilvington S, Larkin DFP, White DG, et al. 1990. Laboratory investigation of Acanthamoeba keratitis. J Clin Microbiol 28:2722-2725.
  31. Lehmann OJ, Green SM, Morlet N, et al. 1998. Polymerase chain reaction analysis of corneal epithelial and tear samples in the diagnosis of Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 39:1261-1265.
  32. Marciano-Cabral F. 2009. Free-living amoeba as agents of human infection. J Infect Dis 199:1104-1106.
  33. Martinez AJ. 1985. Free-living amebas: natural history, prevention, diagnosis, pathology, and treatment of disease. CRC Press, Boca Raton, FL.
  34. McDonnell G, Denver R. 1999. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 12:147-179.
  35. Moore MB, McCulley JP, Luckenback M, et al. 1985. Acanthamoeba keratitis associated with soft contact lenses. Am J Ophthalmol 100:396-403.
  36. Murakawa GJ, McCalmont T, Altman J, et al. 1995. Disseminated acanthamebiasis in patients with AIDS. A report of five cases and a review of the literature. Arch Dermatol 131:1291-1296.
  37. Newton C, Driebe WT, Gordon LR, et al. 1986. Acanthamoeba keratitis associated with contact lenses—United States. MMWR 35:405-408.
  38. Niederkorn JY, Ubelaker JE, McCulley JP, et al. 1992. Susceptibility of corneas from various animal species to in vitro binding and invasion by Acanthamoeba castellanii. Invest Ophthalmol Vis Sci 33:104-112.
  39. Osato M, Robinson N, Wilhelmus K, et al. 1989. Standardization of in vitro antimicrobial susceptibility tests for Acanthamoeba (abstract), p 187. From the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston.
  40. Osato M, Robinson N, Wilhelmus K, et al. The laboratory diagnosis of Acanthamoeba keratitis [abstract], p 187. In the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston.
  41. Pearce JR, Powell HS, Chandler FW, et al. 1985. Amebic meningoencephalitis caused by Acanthamoeba castellanii in a dog. J Am Vet Med Assoc 187:951-952.
  42. Qvarbstrin Y, da Silva AJ, Schuster FL, et al. 2009. Molecular confirmation of Sappinia pedata as a causative agent of amoebic encephalitis. J Infect Dis 199:1139-1142.
  43. 39a. Reed LT, Miller MA, Visvesvara GS, et al. 2010. Cerebral mass in a puppy with respiratory distress and progressive neurologic signs. Vet Pathol 47:1116-1119.
  44. 39b. Richter M, Matheis F, Gonczi E, et al. 2010. Parachlamydia acanthamobae in domestic cats with and without corneal disease. Vet Ophthalmol 13:235-237.
  45. Schuster FL, Guglielmo BJ, Visvesvara GS. 2006. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J Eukaryot Microbiol 53:121-126.
  46. Schuster FL, Visvesvara GS. 2004. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol 34:1001-1027.
  47. Seal DV, Hay J, Kirkness C, et al. 1996. Therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye 10:413-421.
  48. Sharma PP, Gupta P, Murali MV, et al. 1993. Primary amebic meningoencephalitis caused by Acanthamoeba: successfully treated with cotrimoxazole. Indian Pediatr 30:1219-1222.
  49. Siddiqui R, Khan NA, Jarroll EL. 2009. The cyst wall carbohydrate composition of Balamuthia mandrillaris. Parasitol Res 104:1439-1443.
  50. Siddiqui R, Matin A, Warhurst D, et al. 2007. Effect of antimicrobial compounds on Balamuthia mandrillaris encystment and human brain microvascular endothelial cell cytopathogenicity. Antimicrob Agents Chemother 51:4471-4473.
  51. Sison JP, Kemper CA, Loveless M, et al. 1995. Disseminated Acanthamoeba infection in patients with AIDS: case reports and review. Clin Infect Dis 20:1207-1216.
  52. Slater CA, Sickel JZ, Visvesvara GS, et al. 1994. Brief report: successful treatment of disseminated Acanthamoeba infection in an immunocompromised patient. N Engl J Med 331:85-87.
  53. Stothard DR, Shroedeer-Diedrich JM, Awwad MH, et al. 1998. The evolutionary history of the genus Acanthamoeba and the identification of eight new 18S rRNA gene sequence types. J Eukaryot Microbiol 1:45-54.
  54. Tseng ST, Lin S, Chen F. 1998. Is polyhexamethylene biguanide alone effective for keratitis? Cornea 17:345-347.
  55. Visvesvara GS. 2010. Free-living amebae as opportunistic agents of human disease. J Neuroparasitol 1:1-13.
  56. Visvesvara GS. 1985. Free-living pathogenic amoebae, 626-628. In Lennette EH (ed): Manual of clinical microbiology, ed 4. American Society for Microbiology, Washington, DC.
  57. Visvesvara GS, Moura H. Schuster FL. 2007. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol 50:1-26.
  58. Von Bomhard W, Polkinghorne A, Lu ZH, et al. 2003. Detection of novel chlamydiae in cats with ocular disease. Am J Vet Res 64:1421-1427.
  59. Von Bomhard W, Pospischil A, Richter M, et al. 2002. Amoebic infections in cats with ocular disease. Vet Rec 146:556.
  60. Vodkin MH, Howe DK, Visevesvara GS, et al. 1992. Identification of Acanthamoeba at the generic and specific levels using the polymerase chain reaction. J Protozool 39:378-385.
  61. Walochnik J, Obwaller A, Gruber F, et al. 2009. Anti-Acanthamoeba efficacy and toxicity of miltefosine in an organotypic skin equivalent. J Antimicrob Chemother 64:539-545.
  62. Wiley CA, Safrin RE, Davis CE, et al. 1987. Acanthamoeba meningoencephalitis in a patient with AIDS. J Infect Dis 166:130-133.